Loading company
Latest annual · FY2022
Millions- Total revenues
- 0
- Operating income
- 38
- Net income
- (97)
Latest quarter · Q2 FY2023
Millions- Net income
- (11)
PARDES BIOSCIENCES, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2023-03-14 · proof | |
| Net income | -$96.6 million | -$38.5 million | 10-K 2023-03-14 · proof | |
| Cash from operating activities | -$72 million | -$36.9 million | 10-K 2023-03-14 · proof | |
| Total assets | $200.6 million | $275.3 million | -27.1% | 10-K 2023-03-14 · proof |
| Total liabilities | $20.4 million | $9 million | +127.8% | 10-K 2023-03-14 · proof |
| Cash and cash equivalents | $59.3 million | $268.7 million | -77.9% | 10-K 2023-03-14 · proof |
- What was PARDES BIOSCIENCES, INC.'s revenue in fiscal 2022?
- PARDES BIOSCIENCES, INC. reported revenue of $0 for fiscal 2022 (the year ended Dec 31, 2022), against $0 the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What was PARDES BIOSCIENCES, INC.'s net income in fiscal 2022?
- PARDES BIOSCIENCES, INC. reported net income of -$96.6 million for fiscal 2022 (the year ended Dec 31, 2022), against -$38.5 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What was PARDES BIOSCIENCES, INC.'s cash from operating activities in fiscal 2022?
- PARDES BIOSCIENCES, INC. reported cash from operating activities of -$72 million for fiscal 2022 (the year ended Dec 31, 2022), against -$36.9 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What are PARDES BIOSCIENCES, INC.'s total assets?
- As of Dec 31, 2022, PARDES BIOSCIENCES, INC. reported total assets of $200.6 million, against $275.3 million a year earlier (-27.1%). Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What are PARDES BIOSCIENCES, INC.'s total liabilities?
- As of Dec 31, 2022, PARDES BIOSCIENCES, INC. reported total liabilities of $20.4 million, against $9 million a year earlier (+127.8%). Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
- What are PARDES BIOSCIENCES, INC.'s cash and cash equivalents?
- As of Dec 31, 2022, PARDES BIOSCIENCES, INC. reported cash and cash equivalents of $59.3 million, against $268.7 million a year earlier (-77.9%). Source: the 10-K filed with the SEC on Mar 14, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1822711&period_type=annual&limit=5"Information only, not investment advice.